NASDAQ · Biotechnology

AGEN (AGEN) Stock

$7.99 +4.99% NASDAQ: AGEN Healthcare

Valuation

MetricValue
Price$7.99
Market Cap$332.72M
P/E Ratio3.04
P/B Ratio-1.71
P/S Ratio2.59
EPS (TTM)$0.00
52-Week High$8.85
52-Week Low$2.71
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-38.12%
ROA53.28%
ROCE-61.22%
Gross Margin-18.42%
Operating Margin-18.42%
Net Margin69.34%
Debt/Equity-0.20
Current Ratio0.41

Annual Financials (USD)

Metric20212022202320242025
Revenue$296.0M$98.0M$156.0M$103.0M$114.0M
Operating Profit$26.0M$-179.0M$-160.0M$-120.0M$-21.0M
Net Profit$-24.0M$-220.0M$-246.0M$-227.0M$0
EPS$-2.11$-15.64$-13.75$-10.59$0.00
Op Margin8.7%-183.0%-102.1%-116.4%-18.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$466.0M$414.0M$314.0M$226.0M$227.0M
Total Liabilities$418.0M$468.0M$462.0M$533.0M$505.0M
Cash$292.0M$179.0M$76.0M$40.0M$3.0M
Borrowings$58.0M$78.0M$93.0M$95.0M$335.0M

Latest News

AGEN Stock Jumps on Securing $340M Financing to Fund Strategic Pivot Zacks · Jul 14, 2026 Agenus stock doubles as biotech narrows Phase 3 bet TheStreet · Jul 14, 2026 Agenus (AGEN) Moves 82.7% Higher: Will This Strength Last? Zacks · Jul 14, 2026 Agenus (AGEN) Is Up 74.9% After Durable Botensilimab Combo Data In Refractory Colorectal Cancer - Has The Bull Case Changed? Simply Wall St. · Jul 14, 2026 AGEN Stock Eyes Best Day Ever Following Strategic Shift To Earlier Colon Cancer Treatment Stocktwits · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$10.0M$-175.0M$-224.0M$-158.0M$-158.0M
Investing Cash Flow$-77.0M$-87.0M$-7.0M$-1.0M$-1.0M
Financing Cash Flow$6.0M$-3.0M$-4.0M$74.0M$84.0M
Net Cash Flow$192.0M$-113.0M$-102.0M$-36.0M$-36.0M
Free Cash Flow$-24.0M$-228.0M$-234.0M$-159.0M$-159.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA2.35
FCF Yield-28.67%
Quick Ratio0.34
Interest Coverage0.61
Return 1Y1.98%
Return 3Y-80.16%
Return 5Y-95.26%

Ownership

Insiders Held6.72%
Institutions Held23.70%
Institutions Float Held25.41%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC1,440,2322026-03-31
Vanguard Portfolio Management LLC1,195,1092026-03-31
Siren, L.L.C.1,064,2502026-03-31
Marshall Wace LLP688,2032026-03-31
Blackrock Inc.545,6622026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABOS $2.92 +2.46% -1.17 $210.90M 0.00%
FATE $2.43 +1.67% -1.62 $283.24M 0.00%
HURA $2.03 -4.69% -3.75 $129.28M 0.00%
INO $1.33 +4.72% -2.73 $91.89M 0.00%
IRD $3.83 +5.80% -2.99 $316.23M 0.00%

About AGEN

AGEN is led by CEO Garo H. Armen, employs 316 people, headquartered in US, publicly traded since 2000.

AGEN stock trades at $7.99 with a market capitalization of $332.72M. The stock is valued at a price-to-earnings (P/E) ratio of 3.04, price-to-book of -1.71, price-to-sales of 2.59. Over the past 52 weeks the stock has ranged between $2.71 and $8.85, and currently trades 9.7% below its 52-week high.

On profitability, AGEN generates a return on equity (ROE) of -38.12%, return on capital employed of -61.22%, an operating margin of -18.42%, a net profit margin of 69.34%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides